Astrana Health (NASDAQ:ASTH) Sets New 52-Week High – Should You Buy?

Astrana Health, Inc. (NASDAQ:ASTH)’s share price reached a new 52-week high during trading on Tuesday . The stock traded as high as $61.55 and last traded at $61.33, with a volume of 114378 shares. The stock had previously closed at $59.64.

Analyst Ratings Changes

Several analysts have issued reports on ASTH shares. Stifel Nicolaus increased their price objective on shares of Astrana Health from $48.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. BTIG Research lifted their price target on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. KeyCorp initiated coverage on shares of Astrana Health in a research report on Friday. They issued a “sector weight” rating for the company. TD Cowen initiated coverage on Astrana Health in a research report on Monday. They set a “buy” rating and a $66.00 target price on the stock. Finally, Robert W. Baird increased their price target on Astrana Health from $54.00 to $67.00 and gave the company an “outperform” rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $62.00.

Astrana Health Stock Up 2.4 %

The firm has a market cap of $3.42 billion, a P/E ratio of 46.27, a PEG ratio of 2.20 and a beta of 1.21. The firm’s 50-day moving average price is $52.01 and its 200 day moving average price is $45.34. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.84 and a quick ratio of 1.84.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The business had revenue of $486.30 million during the quarter, compared to the consensus estimate of $440.68 million. During the same period in the previous year, the business earned $0.28 EPS. The business’s quarterly revenue was up 39.7% on a year-over-year basis. On average, equities research analysts expect that Astrana Health, Inc. will post 1.33 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. GAMMA Investing LLC acquired a new stake in Astrana Health during the third quarter worth about $34,000. Central Pacific Bank Trust Division bought a new position in shares of Astrana Health during the third quarter valued at approximately $160,000. Granite Bay Wealth Management LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth approximately $290,000. Handelsbanken Fonder AB bought a new stake in shares of Astrana Health in the 3rd quarter worth approximately $492,000. Finally, SG Americas Securities LLC acquired a new position in Astrana Health during the 3rd quarter valued at approximately $680,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.